what is tirzepatide and semaglutide vs. for Weight Loss Tirzepatide vs Semaglutide: A Comprehensive

Hamed K, Alosaimi MN, Ali BA, Alghamdi A, Alkhashi T, Alkhaldi SS et al (2024) Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review

Currently accepted as consisting of two parts, an upper and lower part joined at the modiolus

However, tirzepatide side effects may be more intense due to dual action

Due to semaglutides support of a sustained healthy weight, this class of medications is having a life-changing effect on pre-diabetics and those at risk of developing heart disease, certain cancers, stroke, severe sleep, and other serious systemic conditions

Semaglutide is also the first (and so far only) GLP-1 receptor agonist shown to decrease the risk of heart attacks and strokes among people who dont have diabetes, so thats a game changer in the landscape of obesity medicine, Pedersen says